$FBIZ

Demand deposits to total deposits of First Business Financial Services, Inc. – NASDAQ:FBIZ

This article provides financial data for First Business Financial Services, Inc. (NASDAQ: FBIZ), specifically focusing on the ratio of demand deposits to total deposits. While the complete numerical data is not present in the provided text, the article structure indicates it is a financial brief from TradingView. It highlights key financial information for the regional bank.

Original reporting
Published May 18, 2026, 4:33 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 18, 2026, 5:01 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Demand deposits to total deposits of First Business Financial Services, Inc. – NASDAQ:FBIZ — source image
Decision brief

The 30-second read

$FBIZNeutralLow
01

Why it matters

Changes in the demand deposits to total deposits ratio can affect investor confidence and perceived financial health.

02

Market read

While the ratio provides insight into liquidity, it alone is insufficient for comprehensive trading decisions. Broader financial and economic data should be considered.

03

What to watch

External economic conditions, interest rate trends, and bank-specific developments could significantly influence stock performance beyond this ratio.

Relevance 6/10Timing: short-term (within days to weeks)

Background

Demand deposits are a key component of a bank's liquidity profile, influencing its capacity to lend and meet obligations.

Company-level read

Ticker impact

$FBIZNeutralMedium confidence
Context

Financial data focus on demand deposits to total deposits ratio for First Business Financial Services, Inc.

Expected impact

Limited immediate impact on stock price; potential for moderate positive movement if ratio indicates improved liquidity.

Evidence & confidence

The analysis is based on a single financial ratio without current price or trend data. The neutral sentiment aligns with the lack of significant change indicated in the report.

Market effects

The regional banking sector may experience minor liquidity perception shifts, but no significant sector-wide impact is expected.

Limited regional impact; the data pertains to a specific bank without broader regional implications.

Negligible; the information is specific to a regional bank and does not influence global markets.

Counterpoint

A declining demand deposit ratio could signal liquidity issues, suggesting caution or potential short positions.

Key entities

  • First Business Financial Services, Inc.

    A regional bank listed on NASDAQ, providing banking services to local businesses and individuals.

Related articles

$FBIZMedAI 8/10

FBIZ Q2 2026 Earnings Call Transcript

First Business Financial Services (FBIZ) reported Q2 2026 diluted EPS of $1.84, including $0.14 per share from one-time tax and SBA severance items. Pretax preprovision earnings were $19.8 million, up 15.1% QoQ. NIM rose to 3.78% and guidance for 2026 is 3.60% to 3.65%. The company exited national SBA 7(a) lending and cited capital strength (CET1 9.54%).

$FBIZMed

First Business Financial Services: Q2 Earnings Snapshot

MADISON, Wis. (AP) — MADISON, Wis. (AP) — First Business Financial Services Inc. (FBIZ) on Thursday reported second-quarter net income of $15.6 million. The bank, based in Madison, Wisconsin, said it had earnings of $1.84 per share. Earnings, adjusted for pretax gains, came to $1.70 per share. The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.54 per share.

$FBIZMed

FIRST BUSINESS BANK ANNOUNCES SECOND QUARTER 2026 FINANCIAL RESULTS

FIRST BUSINESS FINANCIAL SERVICES, INC. (FBIZ) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FIRST BUSINESS BANK ANNOUNCES SECOND QUARTER 2026 FINANCIAL RESULTS -- Sustained balance sheet growth and disciplined operating efficiency drive exceptional earnings and tangible book value growth -- MADISON, Wis., July 30, 2026 (BUSINESS WIRE) -- First Business Fina

$GLUEMedAI 8/10

Monte Rosa's MRT-8102 Drives 80%-90% NEK7 Degradation In Phase 1

Monte Rosa Therapeutics (GLUE) reported Phase 1 results showing MRT-8102 achieved 80%-90% NEK7 degradation, reducing biomarkers linked to cardiovascular disease. The treatment was well-tolerated with no serious adverse events. GLUE plans Phase 2 trials in 2026-2027 for coronary artery disease, gout, and hidradenitis suppurativa. GLUE stock is currently down 5.74% at $11.24.